Platelet- and megakaryocyte-derived microparticles

Seminars in Thrombosis and Hemostasis

Volumn 36, Issue 8, 2010, Pages 881-887

  Flaumenhaft, Robert ^a   Mairuhu, Albert T A ^a   Italiano, Joseph E ^b,c  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

cytoskeleton; megakaryocyte; Microparticle; platelet

Indexed keywords

FIBRINOGEN RECEPTOR;

CELL FUNCTION; CIRCULATION; HUMAN; MEGAKARYOCYTE; MOLECULAR MECHANICS; NONHUMAN; PLATELET MICROPARTICLE; PRIORITY JOURNAL; REVIEW; STEM CELL; THROMBOCYTE;

BLOOD PLATELETS; CELL-DERIVED MICROPARTICLES; HUMANS; MEGAKARYOCYTES;

EID: 78149310712     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0030-1267042     Document Type: Review

References (62)

1. Wolf P. The nature and significance of platelet products in human plasma. Br J Haematol 1967 13 (3) 269-288
2. George J N., Thoi L L., McManus L M., Reimann T A. Isolation of human platelet membrane microparticles from plasma and serum. Blood 1982 60 (4) 834-840
3. George J N., Pickett E B., Saucerman S et al. Platelet surface glycoproteins. Studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery. J Clin Invest 1986 78 (2) 340-348
4. Horstman L L., Ahn Y S. Platelet microparticles: a wide-angle perspective. Crit Rev Oncol Hematol 1999 30 (2) 111-142
5. Joop K, Berckmans R J., Nieuwland R et al. Microparticles from patients with multiple organ dysfunction syndrome and sepsis support coagulation through multiple mechanisms. Thromb Haemost 2001 85 (5) 810-820
6. Berckmans R J., Neiuwland R, Bing A N., Romijn F P., Hack C E., Sturk A. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost 2001 85 (4) 639-646
7. Heijnen H F., Schiel A E., Fijnheer R, Geuze H J., Sixma J J. Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood 1999 94 (11) 3791-3799
8. Flaumenhaft R. Formation and fate of platelet microparticles. Blood Cells Mol Dis 2006 36 (2) 182-187
9. Rand M L., Wang H, Bang K W., Packham M A., Freedman J. Rapid clearance of procoagulant platelet-derived microparticles from the circulation of rabbits. J Thromb Haemost 2006 4 (7) 1621-1623
10. Bode A P., Orton S M., Frye M J., Udis B J. Vesiculation of platelets during in vitro aging. Blood 1991 77 (4) 887-895
11. Miyazaki Y, Nomura S, Miyake T et al. High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles. Blood 1996 88 (9) 3456-3464
12. Chow T W., Hellums J D., Thiagarajan P. Thrombin receptor activating peptide (SFLLRN) potentiates shear-induced platelet microvesiculation. J Lab Clin Med 2000 135 (1) 66-72
13. Wiedmer T, Shattil S J., Cunningham M, Sims P J. Role of calcium and calpain in complement-induced vesiculation of the platelet plasma membrane and in the exposure of the platelet factor Va receptor. Biochemistry 1990 29 (3) 623-632
14. Shcherbina A, Remold-O'Donnell E. Role of caspase in a subset of human platelet activation responses. Blood 1999 93 (12) 4222-4231
15. Dale G L., Friese P. Bax activators potentiate coated-platelet formation. J Thromb Haemost 2006 4 (12) 2664-2669
16. Bevers E M., Comfurius P, Zwaal R F. Changes in membrane phospholipid distribution during platelet activation. Biochim Biophys Acta 1983 736 (1) 57-66
17. Zwaal R F., Comfurius P, Bevers E M. Surface exposure of phosphatidylserine in pathological cells. Cell Mol Life Sci 2005 62 (9) 971-988
18. Zwaal R F., Comfurius P, Bevers E M. Scott syndrome, a bleeding disorder caused by defective scrambling of membrane phospholipids. Biochim Biophys Acta 2004 1636 (2-3) 119-128
19. Zhou Q, Zhao J, Wiedmer T, Sims P J. Normal hemostasis but defective hematopoietic response to growth factors in mice deficient in phospholipid scramblase 1. Blood 2002 99 (11) 4030-4038
20. Wiedmer T, Zhao J, Li L et al. Adiposity, dyslipidemia, and insulin resistance in mice with targeted deletion of phospholipid scramblase 3 (PLSCR3). Proc Natl Acad Sci U S A 2004 101 (36) 13296-13301
21. Manno S, Takakuwa Y, Mohandas N. Identification of a functional role for lipid asymmetry in biological membranes: phosphatidylserine-skeletal protein interactions modulate membrane stability. Proc Natl Acad Sci U S A 2002 99 (4) 1943-1948
22. MacDonald R I. Temperature and ionic effects on the interaction of erythroid spectrin with phosphatidylserine membranes. Biochemistry 1993 32 (27) 6957-6964
23. O'Toole P J., Morrison I E., Cherry R J. Investigations of spectrin-lipid interactions using fluoresceinphosphatidylethanolamine as a membrane probe. Biochim Biophys Acta 2000 1466 (12) 39-46
24. Niggli V, Kaufmann S, Goldmann W H., Weber T, Isenberg G. Identification of functional domains in the cytoskeletal protein talin. Eur J Biochem 1994 224 (3) 951-957
25. Razmara M, Hu H, Masquelier M, Li N. Glycoprotein IIb/IIIa blockade inhibits platelet aminophospholipid exposure by potentiating translocase and attenuating scramblase activity. Cell Mol Life Sci 2007 64 (78) 999-1008
26. Niebuhr K, Giuriato S, Pedron T et al. Conversion of PtdIns(4,5)P(2) into PtdIns(5)P by the S. flexneri effector IpgD reorganizes host cell morphology. EMBO J 2002 21 (19) 5069-5078
27. Raucher D, Stauffer T, Chen W et al. Phosphatidylinositol 4,5-bisphosphate functions as a second messenger that regulates cytoskeleton-plasma membrane adhesion. Cell 2000 100 (2) 221-228
28. O'Connell D J., Rozenvayn N, Flaumenhaft R. Phosphatidylinositol 4,5-bisphosphate regulates activation-induced platelet microparticle formation. Biochemistry 2005 44 (16) 6361-6370
29. Wang Y, Litvinov R I., Chen X et al. Loss of PIP5KIgamma, unlike other PIP5KI isoforms, impairs the integrity of the membrane cytoskeleton in murine megakaryocytes. J Clin Invest 2008 118 (2) 812-819
30. Hyvnen M, Macias M J., Nilges M, Oschkinat H, Saraste M, Wilmanns M. Structure of the binding site for inositol phosphates in a PH domain. EMBO J 1995 14 (19) 4676-4685
31. Fukami K, Furuhashi K, Inagaki M, Endo T, Hatano S, Takenawa T. Requirement of phosphatidylinositol 4,5-bisphosphate for alpha-actinin function. Nature 1992 359 (6391) 150-152
32. Tsukita S, Yonemura S. Cortical actin organization: lessons from ERM (ezrin/radixin/moesin) proteins. J Biol Chem 1999 274 (49) 34507-34510
33. Glantz S B., Cianci C D., Iyer R, Pradhan D, Wang K K., Morrow J S. Sequential degradation of alphaII and betaII spectrin by calpain in glutamate or maitotoxin-stimulated cells. Biochemistry 2007 46 (2) 502-513
34. Fox J E., Austin C D., Boyles J K., Steffen P K. Role of the membrane skeleton in preventing the shedding of procoagulant-rich microvesicles from the platelet plasma membrane. J Cell Biol 1990 111 (2) 483-493
35. Fox J E., Austin C D., Reynolds C C., Steffen P K. Evidence that agonist-induced activation of calpain causes the shedding of procoagulant-containing microvesicles from the membrane of aggregating platelets. J Biol Chem 1991 266 (20) 13289-13295
36. Leitinger B, McDowall A, Stanley P, Hogg N. The regulation of integrin function by Ca(2+). Biochim Biophys Acta 2000 1498 (23) 91-98
37. Bass F, Gaffet P, Bienvene A. Correlation between inhibition of cytoskeleton proteolysis and anti-vesiculation effect of calpeptin during A23187-induced activation of human platelets: are vesicles shed by filopod fragmentation? Biochim Biophys Acta 1994 1190 (2) 217-224
38. Cauwenberghs S, Feijge M A., Harper A G., Sage S O., Curvers J, Heemskerk J W. Shedding of procoagulant microparticles from unstimulated platelets by integrin-mediated destabilization of actin cytoskeleton. FEBS Lett 2006 580 (22) 5313-5320
39. Schoenwaelder S M., Yuan Y, Josefsson E C. et al. Two distinct pathways regulate platelet phosphatidylserine exposure and procoagulant function. Blood 2009 114 (3) 663-666
40. Cohen Z, Davis-Gorman G, McDonagh P F., Ritter L. Caspase inhibition of platelet activation. Blood Coagul Fibrinolysis 2008 19 (4) 305-309
41. Mason K D., Carpinelli M R., Fletcher J I. et al. Programmed anuclear cell death delimits platelet life span. Cell 2007 128 (6) 1173-1186
42. Dasgupta S K., Abdel-Monem H, Niravath P et al. Lactadherin and clearance of platelet-derived microvesicles. Blood 2009 113 (6) 1332-1339
43. Cramer E M., Norol F, Guichard J et al. Ultrastructure of platelet formation by human megakaryocytes cultured with the Mpl ligand. Blood 1997 89 (7) 2336-2346
44. Rozmyslowicz T, Majka M, Kijowski J et al. Platelet- and megakaryocyte-derived microparticles transfer CXCR4 receptor to CXCR4-null cells and make them susceptible to infection by X4-HIV. AIDS 2003 17 (1) 33-42
45. Flaumenhaft R, Dilks J R., Richardson J et al. Megakaryocyte-derived microparticles: direct visualization and distinction from platelet-derived microparticles. Blood 2009 113 (5) 1112-1121
46. van der Zee P M., Bir E, K Y et al. P-selectin- and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction. Clin Chem 2006 52 (4) 657-664
47. Cunningham C C. Actin polymerization and intracellular solvent flow in cell surface blebbing. J Cell Biol 1995 129 (6) 1589-1599
48. Charras G T., Hu C K., Coughlin M, Mitchison T J. Reassembly of contractile actin cortex in cell blebs. J Cell Biol 2006 175 (3) 477-490
49. Fackler O T., Grosse R. Cell motility through plasma membrane blebbing. J Cell Biol 2008 181 (6) 879-884
50. Ratajczak J, Wysoczynski M, Hayek F, Janowska-Wieczorek A, Ratajczak M Z. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 2006 20 (9) 1487-1495
51. Baj-Krzyworzeka M, Majka M, Pratico D et al. Platelet-derived microparticles stimulate proliferation, survival, adhesion, and chemotaxis of hematopoietic cells. Exp Hematol 2002 30 (5) 450-459
52. Morel O, Toti F, Hugel B, Freyssinet J M. Cellular microparticles: a disseminated storage pool of bioactive vascular effectors. Curr Opin Hematol 2004 11 (3) 156-164
53. Mack M, Kleinschmidt A, Brhl H et al. Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: a mechanism for cellular human immunodeficiency virus 1 infection. Nat Med 2000 6 (7) 769-775
54. Janowska-Wieczorek A, Majka M, Kijowski J et al. Platelet-derived microparticles bind to hematopoietic stem/progenitor cells and enhance their engraftment. Blood 2001 98 (10) 3143-3149
55. Barry O P., Pratico D, Lawson J A., FitzGerald G A. Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. J Clin Invest 1997 99 (9) 2118-2127
56. Barry O P., Pratic D, Savani R C., FitzGerald G A. Modulation of monocyte-endothelial cell interactions by platelet microparticles. J Clin Invest 1998 102 (1) 136-144
57. Raposo G, Nijman H W., Stoorvogel W et al. B lymphocytes secrete antigen-presenting vesicles. J Exp Med 1996 183 (3) 1161-1172
58. Denzer K, van Eijk M, Kleijmeer M J., Jakobson E, de Groot C, Geuze H J. Follicular dendritic cells carry MHC class II-expressing microvesicles at their surface. J Immunol 2000 165 (3) 1259-1265
59. Clayton A, Turkes A, Dewitt S, Steadman R, Mason M D., Hallett M B. Adhesion and signaling by B cell-derived exosomes: the role of integrins. FASEB J 2004 18 (9) 977-979
60. Ratajczak J, Miekus K, Kucia M et al. Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia 2006 20 (5) 847-856
61. Deregibus M C., Cantaluppi V, Calogero R et al. Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood 2007 110 (7) 2440-2448
62. Hunter M P., Ismail N, Zhang X et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS One 2008 3 (11) e3694